Maintaining high rates of measles immunization in Africa

Epidemiology and Infection

Volumn 139, Issue 7, 2011, Pages 1039-1049

  Lessler, J ^a   Moss, W J ^a   Lowther, S A ^a   Cummings, D A T ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Measles (rubeola); vaccination (immunization)

Indexed keywords

MEASLES VACCINE;

ARTICLE; CHILD; CONTROL STRATEGY; CONTROLLED STUDY; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFANT; INFECTION CONTROL; INFECTION PREVENTION; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; PREDICTION; PRESCHOOL CHILD; PROCESS DEVELOPMENT; RUBELLA; SIMULATION; VIRUS IMMUNITY; VIRUS TRANSMISSION; ZAMBIA;

AGE FACTORS; ANTIBODIES, VIRAL; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; MEASLES; MEASLES VACCINE; MEASLES VIRUS; QUESTIONNAIRES; ZAMBIA;

EID: 79959339157     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810002232     Document Type: Article

References (27)

1. World Health Organization, United Nations Children's Fund. Measles mortality reduction and regional elimination strategic plan 2001-2005. Geneva: WHO, 2001.
2. Centers for Disease Prevention and Control. Progress in global measles control and mortality reduction, 2000-2006. Morbidity and Mortality Weekly Report 2007; 56:1237-1241.
3. World Health Organization, United Nations Children's Fund. GIVS: Global Immunization Vision and Strategy 2006-2015. Geneva: WHO, 2005.
4. Orenstein WA, et al. Measles eradication : is it in our future? American Journal of Public Health 2000; 90:1521-1525.
5. World Health Organization. World Health Organization Regional Office for Africa Measles SIAs Field Guide. Geneva: WHO, 2006.
6. Agur Z, et al. Pulse mass measles vaccination across age cohorts. Proceedings of the National Academy of Sciences USA 1993; 90: 11698-11702. (Pubitemid 24008706)
7. Shulgin B, Stone L, Agur Z. Pulse vaccination strategy in the SIR epidemic model. Bulletin of Mathematical Biology 1998; 60: 1123-1148. (Pubitemid 28559961)
8. Nokes DJ, Swinton J. The control of childhood viral infections by pulse vaccination. IMA Journal of Mathematics Applied in Medicine and Biology 1995; 12:29-53.
9. WHO. Measles vaccines : WHO position paper. Weekly Epidemiological Record 2009; 84: 349-360.
10. Pan C et al. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus monkeys from measles. Journal of Virology 2010; 84: 3798-3807.
11. Griffin D, Pan C, Moss WJ. Measles vaccines. Frontiers in Bioscience 2008; 13: 1352-1370. (Pubitemid 351606114)
12. Hethcote HW. The mathematics of infectious diseases. SIAM Review 2000; 42: 599-653.
13. Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford; New York: Oxford University Press, 1991.
14. Grais RF, et al. Estimating transmission intensity for a measles epidemic in Niamey, Niger: lessons for intervention. Transactions of the Royal Society of Tropical Medicine and Hygiene 2006; 100: 867-873. (Pubitemid 43986284)
15. Scott S, et al. Estimating the force of measles virus infection from hospitalised cases in Lusaka, Zambia. Vaccine 2004; 23: 732-738. (Pubitemid 39473170)
16. World Health Organization. Progress in measles control: Zambia, 1999-2004. Weekly Epidemiological Record 2005; 24: 213-220.
17. Lowther SA, et al. Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey. Lancet 2009; 373: 1025-1032.
18. Venables WN, Ripley BD. Modern Applied Statistics with S-PLUS, 3rd edn. New York: Springer, 1999.
19. Caceres VM, Strebel PM, Sutter RW. Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clinical Infectious Diseases 2000; 31: 110-119. (Pubitemid 32268948)
20. Gans HA, et al. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. Journal of the American Medical Association 1998; 280: 527-532. (Pubitemid 28377671)
21. Government of the Republic of Zambia. Zambia Demographic and Health Survey 2001-2002. Central Statistical Office (Zambia) CBHZORCM, ed. Lusaka and Maryland: Central Board of Health and ORC Macro, 2003.
22. U.S. Census Bureau. U.S. Census Bureau International Database (IDB) (http://www.census.gov/ipc/www/idb/worldpop.html). Accessed 1 June 2008.
23. Duda RO, Hart PE, Stork DG. Pattern Classification, 2nd edn. New York: Wiley, 2001.
24. Ohuma EO, et al. Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district : interpretation of antibody prevalence data using mixture models. Epidemiology and Infection 2009; 137: 227-233.
25. Wood JG, et al. Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia. Vaccine 2009; 27: 313-318.
26. World Health Organization. Report of the Second Measles Technical Advisory Group Meeting. Addis Ababa, 8-9 May 2008 (http://www.afro.who.int/ measles/2ndtagmeeting/index.html). Accessed 15 August 2009.
27. World Health Organization. WHO Department of Immunization, Vaccines and Biologicals. Vaccine preventable diseases : monitoring system (http://www.who.int/vaccines/globalsummary/immunization/countryprofileselect. cfm). Accessed 8 May 2008.